Last reviewed · How we verify
NCT05026242: AlmondIS
Effects of Almond Consumption on Innate and Adaptive Immune System
NA trial testing Almond intervention in Immune System in 110 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2024
Quick facts
| Lead sponsor | Institut Investigacio Sanitaria Pere Virgili |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 1 September 2021 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Almond intervention
- Control
Conditions studied
- Immune System — all drugs for Immune System →
Sponsor
Institut Investigacio Sanitaria Pere Virgili — full company profile →
Who can join
Adults 40 to 65, any sex, with Immune System. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Almonds are a rich matrix of different nutrients with demonstrated benefits on immune system. This proposal examines the effect of regular consumption of almonds on innate and adaptive immune system in healthy individuals with overweight regularly consuming a Western-style diet and unhealthy snacks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05026242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Immune System
Currently open trials in the same condition.
- NCT07020156 — A First-in-Human Phase I Trial of OX118 in Healthy Volunteers · Phase 1 · recruiting
- NCT06470607 — The Lymphocytic Infiltrate of Lung Tumors. · recruiting
- NCT05334888 — Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach · recruiting
- NCT06683248 — The Effects of Night Shift Work on Health Across the Menstrual Cycle · NA · recruiting
Other Institut Investigacio Sanitaria Pere Virgili trials
Trials by the same sponsor.
- NCT07205978 — Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis · active not recruiting
- NCT07124923 — Continuous Care Intervention in Primary Care to Improve Type 2 Diabetes Control in Terres de l'Ebre, Catalonia · NA · recruiting
- NCT07427056 — Impact of the War in Ukraine on the Mental Health of Refugees Residing in Spain · completed
- NCT06775509 — Optical Quality of the Cornea in Orthokeratology · NA · active not recruiting
- NCT06395246 — Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05026242 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut Investigacio Sanitaria Pere Virgili
- Last refreshed: 18 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05026242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing